Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Sesen Bio Inc

(NASDAQ: SESN)
Add to Portfolio
+0.05 (+4.42%)
as of Sep 16, 2019

Growing Global Demand for Non-Invasive Cellulite

PR Newswire via COMTEX - Wed May 29, 08:50AM EDT
Cellulite affects 85% to 90% of all women worldwide and was first described nearly 100 years ago, and has been the bane of women (and men) ever since. But to find a 'cure' or effective 'solution' the cause must be understood. Firs(full story)
BSX: 41.94 (+0.13), SESN: 1.18 (+0.05), SWAV: 32.85 (+2.18), PFE: 36.83 (-0.08), SOLY: 14.18 (+0.92)

Positive Results and New Technology Give Rise to

GlobeNewswire via COMTEX - Wed Mar 27, 08:00AM EDT
Investorideas.com, a leading investor news resource covering biotech and pharma stocks releases a snapshot looking at the biopharmaceutical market and how monoclonal antibody research is gaining market dominance.(full story)
IPATF: 0.4190 (+0.0081), ARFXF: 0.1775 (-0.0009), IPA.VN: 0.550 (unch), SESN: 1.18 (+0.05), PMN.TO: 0.23 (-0.01), ZYME: 25.83 (+0.21), ZYME.TO: 34.25 (+0.24)

Demand for Cancer Treatment Remains High Despite

PR Newswire via COMTEX - Wed Feb 13, 09:00AM EST
Deaths related to cancer dropped by 27% in the past quarter-century, meaning that 2.6 million fewer people died due to cancer during that time period, according to a report by the American Cancer Society. Researchers noted that fo(full story)
ABIO: 6.43 (+0.35), SESN: 1.18 (+0.05), NAVB: 0.73 (+0.03), SNETD: 0.3900 (+0.0500), SNET: 0.0103 (+0.0040), CGIX: 0.09 (unch)